Cargando…

Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus

The two-pore domain K(+) (K(2P)) channel, which is involved in setting the resting membrane potential in neurons, is an essential target for receptor agonists. Activation of the γ-aminobutyric acid (GABA) receptors (GABA(A)R and GABA(B)R) reduces cellular excitability through Cl(-) influx and K(+) e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eun-Jin, Kwon, Oh-Sang, Hur, Chang-Gi, Nyiramana, Marie Merci, Lee, Dong-Kun, Hong, Seong-Geun, Han, Jaehee, Kang, Dawon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431218/
https://www.ncbi.nlm.nih.gov/pubmed/34502229
http://dx.doi.org/10.3390/ijms22179320
_version_ 1783750885374951424
author Kim, Eun-Jin
Kwon, Oh-Sang
Hur, Chang-Gi
Nyiramana, Marie Merci
Lee, Dong-Kun
Hong, Seong-Geun
Han, Jaehee
Kang, Dawon
author_facet Kim, Eun-Jin
Kwon, Oh-Sang
Hur, Chang-Gi
Nyiramana, Marie Merci
Lee, Dong-Kun
Hong, Seong-Geun
Han, Jaehee
Kang, Dawon
author_sort Kim, Eun-Jin
collection PubMed
description The two-pore domain K(+) (K(2P)) channel, which is involved in setting the resting membrane potential in neurons, is an essential target for receptor agonists. Activation of the γ-aminobutyric acid (GABA) receptors (GABA(A)R and GABA(B)R) reduces cellular excitability through Cl(-) influx and K(+) efflux in neurons. Relatively little is known about the link between GABA(A)R and the K(+) channel. The present study was performed to identify the effect of GABAR agonists on K(2P) channel expression and activity in the neuroblastic B35 cells that maintain glutamic acid decarboxylase (GAD) activity and express GABA. TASK and TREK/TRAAK mRNA were expressed in B35 cells with a high level of TREK-2 and TRAAK. In addition, TREK/TRAAK proteins were detected in the GABAergic neurons obtained from GABA transgenic mice. Furthermore, TREK-2 mRNA and protein expression levels were markedly upregulated in B35 cells by GABA(A)R and GABA(B)R agonists. In particular, muscimol, a GABA(A)R agonist, significantly increased TREK-2 expression and activity, but the effect was reduced in the presence of the GABA(A)R antagonist bicuculine or TREK-2 inhibitor norfluoxetine. In the whole-cell and single-channel patch configurations, muscimol increased TREK-2 activity, but the muscimol effect disappeared in the N-terminal deletion mutant. These results indicate that muscimol directly induces TREK-2 activation through the N-terminus and suggest that muscimol can reduce cellular excitability by activating the TREK-2 channel and by inducing Cl(-) influx in GABAergic neurons.
format Online
Article
Text
id pubmed-8431218
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84312182021-09-11 Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus Kim, Eun-Jin Kwon, Oh-Sang Hur, Chang-Gi Nyiramana, Marie Merci Lee, Dong-Kun Hong, Seong-Geun Han, Jaehee Kang, Dawon Int J Mol Sci Article The two-pore domain K(+) (K(2P)) channel, which is involved in setting the resting membrane potential in neurons, is an essential target for receptor agonists. Activation of the γ-aminobutyric acid (GABA) receptors (GABA(A)R and GABA(B)R) reduces cellular excitability through Cl(-) influx and K(+) efflux in neurons. Relatively little is known about the link between GABA(A)R and the K(+) channel. The present study was performed to identify the effect of GABAR agonists on K(2P) channel expression and activity in the neuroblastic B35 cells that maintain glutamic acid decarboxylase (GAD) activity and express GABA. TASK and TREK/TRAAK mRNA were expressed in B35 cells with a high level of TREK-2 and TRAAK. In addition, TREK/TRAAK proteins were detected in the GABAergic neurons obtained from GABA transgenic mice. Furthermore, TREK-2 mRNA and protein expression levels were markedly upregulated in B35 cells by GABA(A)R and GABA(B)R agonists. In particular, muscimol, a GABA(A)R agonist, significantly increased TREK-2 expression and activity, but the effect was reduced in the presence of the GABA(A)R antagonist bicuculine or TREK-2 inhibitor norfluoxetine. In the whole-cell and single-channel patch configurations, muscimol increased TREK-2 activity, but the muscimol effect disappeared in the N-terminal deletion mutant. These results indicate that muscimol directly induces TREK-2 activation through the N-terminus and suggest that muscimol can reduce cellular excitability by activating the TREK-2 channel and by inducing Cl(-) influx in GABAergic neurons. MDPI 2021-08-27 /pmc/articles/PMC8431218/ /pubmed/34502229 http://dx.doi.org/10.3390/ijms22179320 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Eun-Jin
Kwon, Oh-Sang
Hur, Chang-Gi
Nyiramana, Marie Merci
Lee, Dong-Kun
Hong, Seong-Geun
Han, Jaehee
Kang, Dawon
Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus
title Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus
title_full Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus
title_fullStr Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus
title_full_unstemmed Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus
title_short Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus
title_sort muscimol directly activates the trek-2 channel expressed in gabaergic neurons through its n-terminus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431218/
https://www.ncbi.nlm.nih.gov/pubmed/34502229
http://dx.doi.org/10.3390/ijms22179320
work_keys_str_mv AT kimeunjin muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus
AT kwonohsang muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus
AT hurchanggi muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus
AT nyiramanamariemerci muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus
AT leedongkun muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus
AT hongseonggeun muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus
AT hanjaehee muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus
AT kangdawon muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus